Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Brought to you by

SpePharm gets €16mm in private round

01 Oct 2020

Executive Summary

SpePharm Holdings BV (cancer and critical care therapeutics) raised €16mm ($23.6mm) through a private financing from TVM Capital, Signet Healthcare Partners, Paul Capital Healthcare, and members of the company's senior management team. SpePharm concurrently announced a €10mm revenue interest acquisition financing agreement signed with Paul Capital to fund the recent purchase of European rights to Dantrium for hyperthermia from Procter & Gamble.

Deal Industry
  • Pharmaceuticals
  • Pharmaceuticals
    • Specialty Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies

UsernamePublicRestriction

Register

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By